Allergan racked up another indication for Botox (onabotulinumtoxinA) – known mostly for its antiwrinkle capabilities – this time to treat overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency and frequency but are unable to use or have had an inadequate response to anticholinergics.
Allergan racked up another indication for Botox (onabotulinumtoxinA) – known mostly for its antiwrinkle capabilities – this time to treat overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency and frequency but are unable to use or have had an inadequate response to anticholinergics.
The latest win makes it the eighth medical indication for Botox in the US, the Irvine, California-based company said.
The Danish medical dermatology specialist doubles boosts its sales force ahead of the launch of Anzupgo.
Sun’s Leqselvi goes up against Lilly's Olumiant and Pfizer's Litfulo, which currently has the broadest label, in the US alopecia market. Can it shake things up early, amid growing activity in the space with several new mechanisms of action being investigated?
Paying €90m upfront for rights to generalized pustular psoriasis drug.
Apogee Therapeutics reports data from Phase II APEX trial of its long-acting antibody against atopic dermatitis, showing similar efficacy to Regeneron/Sanofi’s Dupixent and Eli Lilly’s Ebglyss.
